Featured Research

from universities, journals, and other organizations

Scientists Decode Genome Of Oral Pathogen

Date:
April 6, 2007
Source:
Virginia Commonwealth University
Summary:
Scientists have decoded the genome of a bacteria normally present in the healthy human mouth that can cause a deadly heart infection if it enters the bloodstream.

Transmission electron micrograph of S. sanguinis.
Credit: Image courtesy of Lauren Turner/VCU

Virginia Commonwealth University researchers have decoded the genome of a bacteria normally present in the healthy human mouth that can cause a deadly heart infection if it enters the bloodstream.

Related Articles


The finding enables scientists to better understand the organism, Streptococcus sanguinis, and develop new strategies for treatment and infection prevention.

S. sanguinis, a type of bacteria that is naturally present in the mouth, is among a variety of microorganisms responsible for the formation of dental plaque. In general, S. sanguinis is harmless. However, if it enters the bloodstream, possibly through a minor cut or wound in the mouth, it can cause bacterial endocarditis, a serious and often lethal infection of the heart.

Individuals with preexisting heart problems are at an increased risk of developing bacterial endocarditis. The infection may result in impaired heart function and complications such as heart attack and stroke. Typically, before dental surgery, such patients are given high dose antibiotics to prevent infection.

Decoding S. sanguinis, a streptococcal bacteria, will provide researchers with unique insight into its complex life cycle, metabolism and its ability to invade the host and cause bacterial endocarditis.

"We can apply this information toward the design of new treatments and preventative strategies to protect against this disease," said lead investigator, Francis Macrina, Ph.D., VCU's vice president for research. "Analysis of the genome revealed a surprising number of proteins on the S. sanguinis cell surface that may be new targets for drugs or vaccines. We are already at work pursuing some of these leads."

Although it is not directly associated with tooth decay or gum disease, S. sanguinis is a prominent member of dental plaque. "Genomic studies of this organism will also help us better understand the formation of dental plaque and the initiation of oral diseases," added Macrina.

The team reported that the genome of the gram-positive bacterium is a circular DNA molecule consisting of approximately 2.4 million base pairs. They analyzed the S. sanguinis genome and found that it was larger than other streptococci that have been sequenced. Some of this extra DNA was apparently adopted from another bacterium and encodes genes that may give S. sanguinis the ability to survive better in the face of good oral hygiene. If so, this could explain the recent emergence of S. sanguinis as an important pathogen.

"The sequence of the S. sanguinis genome gives us a comprehensive view of the biological potential of this important pathogen," said Gregory A. Buck, Ph.D., director of the Center for the Study of Biological Complexity at VCU, who directed the sequencing and analysis. "This data opens a window into the inner workings of this bacterium. We now may be able to determine how and why these organisms cause disease."

The findings were reported in the April 2007 issue of the Journal of Bacteriology, which is published by the American Society of Microbiology.

This work was supported by the National Institute of Dental and Craniofacial Research and the National Institute of Allergy and Infectious Disease.

Macrina and Buck collaborated with other VCU researchers from the Philips Institute of Oral and Craniofacial Molecular Biology, the Center for the Study of Biological Complexity, the Department of Microbiology and Immunology and the Department of Biochemistry and Molecular Biophysics. Joao M. Alves and Ping Xu, Ph.D., share the honor of first authorship on this manuscript. Other researchers included Todd Kitten, Ph.D., Zhenming Chen, Ph.D., Luiz S. Ozki, Ph.D., Patricio Manque, Ph.D., Myrna G. Serrano, Ph.D., Arunsri Brown, Ph.D., Xiuchun Ge, Ph.D., Daniela Puiu Ph.D., Stephanie Hendricks, Ph.D., Yingping Wang, Ph.D., Michael D. Chaplin, Ph.D., Doruk Akan, Ph.D., Sehmi Paik, Ph.D., and Darrell L. Peterson, Ph.D.


Story Source:

The above story is based on materials provided by Virginia Commonwealth University. Note: Materials may be edited for content and length.


Cite This Page:

Virginia Commonwealth University. "Scientists Decode Genome Of Oral Pathogen." ScienceDaily. ScienceDaily, 6 April 2007. <www.sciencedaily.com/releases/2007/04/070405180524.htm>.
Virginia Commonwealth University. (2007, April 6). Scientists Decode Genome Of Oral Pathogen. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2007/04/070405180524.htm
Virginia Commonwealth University. "Scientists Decode Genome Of Oral Pathogen." ScienceDaily. www.sciencedaily.com/releases/2007/04/070405180524.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins